LL-paraoxonase genotype is associated with a more severe degree of homeostasis model assessment IR in healthy subjects.
暂无分享,去创建一个
[1] G. Paolisso,et al. Oxidative stress and insulin action: is there a relationship? , 1996, Diabetologia.
[2] G. Schellenberg,et al. Paraoxonase (PON1) Phenotype Is a Better Predictor of Vascular Disease Than Is PON1192 or PON155 Genotype , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[3] A. Gardemann,et al. The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease. , 2000, Atherosclerosis.
[4] E. Anggard,et al. Antioxidants, diabetes and endothelial dysfunction. , 2000, Cardiovascular research.
[5] Y. Yazaki,et al. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. , 2000, Atherosclerosis.
[6] J. Ferrières,et al. Paraoxonase activity in two healthy populations with differing rates of coronary heart disease , 2000, European journal of clinical investigation.
[7] G. Schellenberg,et al. Paraoxonase ( PON 1 ) Phenotype Is a Better Predictor of Vascular Disease Than Is PON 1 192 or PON 1 55 Genotype , 2000 .
[8] A. Gardemann,et al. The paraoxonase Leu – Met 54 and Gln – Arg 191 gene polymorphisms are not associated with the risk of coronary heart disease , 2000 .
[9] E. Bonora,et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. , 2000, Diabetes care.
[10] Paolisso,et al. Advancing age and insulin resistance: new facts about an ancient history , 1999, European journal of clinical investigation.
[11] T. Lehtimäki,et al. Association between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects , 1999, Human Genetics.
[12] A. Rudich,et al. Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes , 1999, Diabetologia.
[13] A. Rudich,et al. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. , 1998, Diabetes.
[14] T. Dantoine,et al. Paraoxonase as a Risk Marker for Cardiovascular Disease: Facts and Hypotheses , 1998, Clinical chemistry and laboratory medicine.
[15] P. Zimmet,et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[16] D. Sanghera,et al. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. , 1998, American journal of human genetics.
[17] A. Lusis,et al. Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis? , 1998, American journal of human genetics.
[18] R. James,et al. Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[19] A. Rudich,et al. Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats. , 1997, Metabolism: clinical and experimental.
[20] P. Froguel,et al. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. , 1997, The Journal of clinical investigation.
[21] M. Jauhiainen,et al. The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. , 1996, The Journal of clinical investigation.
[22] D. Moller,et al. Candidate Genes for Insulin Resistance , 1996, Diabetes Care.
[23] M. Laakso,et al. Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[24] D. Adler,et al. The molecular basis of the human serum paraoxonase activity polymorphism , 1993, Nature Genetics.
[25] R. DeFronzo,et al. Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.
[26] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[27] J. Ziegenhorn,et al. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. , 1983, Clinical chemistry.
[28] E. Voutilainen,et al. Comparison of different analytical and precipitation methods for direct estimation of serum high-density lipoprotein cholesterol. , 1981, Scandinavian journal of clinical and laboratory investigation.
[29] A. Wahlefeld. Triglycerides Determination after Enzymatic Hydrolysis , 1974 .